Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 382-392
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.382
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.382
Marker | Staining pattern | Useful for |
Smooth muscle actin | Cytoplasmic staining | Myoepithelial differentiation |
Calponin | Cytoplasmic staining | Myoepithelial differentiation |
p63 | Nuclear | Myoepithelial differentiation |
Smooth muscle myosin heavy chain | Cytoplasmic | Myoepithelial differentiation |
CD10 | Membranous staining | Myoepithelial differentiation |
S100 | Cytoplasmic | Myoepithelial differentiation |
High-molecular-weight cytokeratins (14 and 5/6) | Cytoplasmic | To distinguish invasive carcinoma from benign proliferations; expressed by lobular carcinomas |
Cytokeratin 8 | Peripheral cytoplasmic | Ductal carcinoma cells |
Cytokeratin 8 | Perinuclear staining | Lobular carcinoma cells |
CK 7 and 20 | Mammary origin of a metastatic carcinoma | |
E-cadherin | Membranous staining | Usual ductal carcinomas |
Hormone receptors estrogen receptor, progesterone receptor | Nuclear | Identified subtypes, mammary origin |
HER2 neu | Membranous staining | Identified subtypes |
Gross cystic disease fluid protein 15 | Cytoplasmic | Mammary origin of a metastatic carcinoma |
Mammaglobin A | Cytoplasmic | Mammary origin of a metastatic carcinoma |
Carcinoembryonic antigen, CEAD-14 clone | Cytoplasmic | Evaluation of metastatic mammary carcinoma |
- Citation: Zaha DC. Significance of immunohistochemistry in breast cancer. World J Clin Oncol 2014; 5(3): 382-392
- URL: https://www.wjgnet.com/2218-4333/full/v5/i3/382.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i3.382